nodes	percent_of_prediction	percent_of_DWPC	metapath
Fentanyl—OPRD1—forebrain—attention deficit hyperactivity disorder	0.0339	0.115	CbGeAlD
Fentanyl—OPRK1—forebrain—attention deficit hyperactivity disorder	0.0325	0.111	CbGeAlD
Fentanyl—OPRM1—forebrain—attention deficit hyperactivity disorder	0.0231	0.0786	CbGeAlD
Fentanyl—Phenoxybenzamine—ADRA2C—attention deficit hyperactivity disorder	0.0198	0.184	CrCbGaD
Fentanyl—Bepridil—CACNA1C—attention deficit hyperactivity disorder	0.0187	0.174	CrCbGaD
Fentanyl—OPRD1—nervous system—attention deficit hyperactivity disorder	0.0184	0.0626	CbGeAlD
Fentanyl—Diphenylpyraline—SLC6A3—attention deficit hyperactivity disorder	0.0183	0.17	CrCbGaD
Fentanyl—OPRD1—central nervous system—attention deficit hyperactivity disorder	0.0177	0.0603	CbGeAlD
Fentanyl—OPRK1—nervous system—attention deficit hyperactivity disorder	0.0176	0.06	CbGeAlD
Fentanyl—OPRK1—central nervous system—attention deficit hyperactivity disorder	0.017	0.0578	CbGeAlD
Fentanyl—OPRK1—cerebellum—attention deficit hyperactivity disorder	0.0166	0.0565	CbGeAlD
Fentanyl—OPRM1—midbrain—attention deficit hyperactivity disorder	0.0152	0.0519	CbGeAlD
Fentanyl—Benzatropine—SLC6A3—attention deficit hyperactivity disorder	0.0141	0.131	CrCbGaD
Fentanyl—OPRD1—brain—attention deficit hyperactivity disorder	0.014	0.0478	CbGeAlD
Fentanyl—OPRK1—brain—attention deficit hyperactivity disorder	0.0135	0.0459	CbGeAlD
Fentanyl—OPRM1—nervous system—attention deficit hyperactivity disorder	0.0125	0.0427	CbGeAlD
Fentanyl—OPRM1—central nervous system—attention deficit hyperactivity disorder	0.0121	0.0411	CbGeAlD
Fentanyl—Modafinil—SLC6A3—attention deficit hyperactivity disorder	0.0104	0.0967	CrCbGaD
Fentanyl—OPRM1—brain—attention deficit hyperactivity disorder	0.00958	0.0326	CbGeAlD
Fentanyl—Benzphetamine—SLC6A3—attention deficit hyperactivity disorder	0.00903	0.0838	CrCbGaD
Fentanyl—Benzphetamine—ADRA2A—attention deficit hyperactivity disorder	0.00885	0.0822	CrCbGaD
Fentanyl—Phenoxybenzamine—ADRA2A—attention deficit hyperactivity disorder	0.00846	0.0785	CrCbGaD
Fentanyl—ABCB1—forebrain—attention deficit hyperactivity disorder	0.00666	0.0227	CbGeAlD
Fentanyl—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00563	0.0192	CbGeAlD
Fentanyl—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00511	0.0174	CbGeAlD
Fentanyl—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00492	0.0167	CbGeAlD
Fentanyl—ABCB1—midbrain—attention deficit hyperactivity disorder	0.0044	0.015	CbGeAlD
Fentanyl—OPRD1—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00384	0.00642	CbGpPWpGaD
Fentanyl—OPRK1—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00381	0.00636	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00381	0.00636	CbGpPWpGaD
Fentanyl—OPRD1—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.0038	0.00634	CbGpPWpGaD
Fentanyl—OPRD1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00375	0.00626	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00373	0.00624	CbGpPWpGaD
Fentanyl—OPRM1—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.00368	0.00615	CbGpPWpGaD
Fentanyl—OPRD1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00363	0.00606	CbGpPWpGaD
Fentanyl—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00362	0.0123	CbGeAlD
Fentanyl—OPRD1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00357	0.00596	CbGpPWpGaD
Fentanyl—OPRD1—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00354	0.00591	CbGpPWpGaD
Fentanyl—OPRK1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00353	0.0059	CbGpPWpGaD
Fentanyl—OPRD1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00352	0.00588	CbGpPWpGaD
Fentanyl—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.00348	0.0119	CbGeAlD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00346	0.00579	CbGpPWpGaD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00345	0.00577	CbGpPWpGaD
Fentanyl—OPRK1—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00343	0.00573	CbGpPWpGaD
Fentanyl—OPRM1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00342	0.00571	CbGpPWpGaD
Fentanyl—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.0034	0.0116	CbGeAlD
Fentanyl—OPRD1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00339	0.00566	CbGpPWpGaD
Fentanyl—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00338	0.00565	CbGpPWpGaD
Fentanyl—OPRK1—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00337	0.00563	CbGpPWpGaD
Fentanyl—OPRK1—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00333	0.00556	CbGpPWpGaD
Fentanyl—OPRK1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00329	0.00549	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00328	0.00548	CbGpPWpGaD
Fentanyl—OPRD1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00328	0.00548	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00327	0.00547	CbGpPWpGaD
Fentanyl—OPRM1—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00322	0.00538	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00322	0.00537	CbGpPWpGaD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00321	0.00536	CbGpPWpGaD
Fentanyl—OPRK1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00318	0.00532	CbGpPWpGaD
Fentanyl—OPRK1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00313	0.00522	CbGpPWpGaD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00311	0.00519	CbGpPWpGaD
Fentanyl—OPRK1—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.0031	0.00518	CbGpPWpGaD
Fentanyl—OPRK1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00309	0.00516	CbGpPWpGaD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00306	0.00511	CbGpPWpGaD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00303	0.00506	CbGpPWpGaD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00302	0.00504	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00301	0.00503	CbGpPWpGaD
Fentanyl—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00299	0.00499	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00297	0.00497	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00293	0.00489	CbGpPWpGaD
Fentanyl—OPRM1—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.0029	0.00484	CbGpPWpGaD
Fentanyl—OPRK1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00288	0.00481	CbGpPWpGaD
Fentanyl—OPRM1—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00285	0.00476	CbGpPWpGaD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00282	0.0047	CbGpPWpGaD
Fentanyl—OPRM1—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00281	0.0047	CbGpPWpGaD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00281	0.0047	CbGpPWpGaD
Fentanyl—OPRM1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00278	0.00464	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00277	0.00462	CbGpPWpGaD
Fentanyl—ABCB1—brain—attention deficit hyperactivity disorder	0.00276	0.00941	CbGeAlD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00273	0.00455	CbGpPWpGaD
Fentanyl—OPRM1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00269	0.00449	CbGpPWpGaD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00268	0.00448	CbGpPWpGaD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00265	0.00442	CbGpPWpGaD
Fentanyl—OPRM1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00264	0.00442	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00264	0.00441	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00263	0.00439	CbGpPWpGaD
Fentanyl—OPRM1—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00262	0.00438	CbGpPWpGaD
Fentanyl—OPRM1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00261	0.00436	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00256	0.00427	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00251	0.0042	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.0025	0.00418	CbGpPWpGaD
Fentanyl—CYP3A7—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.0025	0.00418	CbGpPWpGaD
Fentanyl—CYP3A7—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00249	0.00415	CbGpPWpGaD
Fentanyl—CYP3A7—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00247	0.00412	CbGpPWpGaD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00247	0.00412	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00245	0.0041	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00244	0.00408	CbGpPWpGaD
Fentanyl—OPRM1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00243	0.00406	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00238	0.00397	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00237	0.00395	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00233	0.00389	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00231	0.00385	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.0023	0.00385	CbGpPWpGaD
Fentanyl—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.0023	0.00384	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.0023	0.00384	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00227	0.0038	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00226	0.00378	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00224	0.00374	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00223	0.00372	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00223	0.00372	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.0022	0.00367	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00215	0.00359	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00214	0.00358	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00214	0.00358	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00208	0.00348	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00208	0.00347	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00204	0.00341	CbGpPWpGaD
Fentanyl—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00202	0.00337	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00202	0.00337	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.002	0.00334	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00199	0.00333	CbGpPWpGaD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00197	0.00329	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00195	0.00326	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00195	0.00326	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00188	0.00314	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00186	0.0031	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00182	0.00304	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00181	0.00303	CbGpPWpGaD
Fentanyl—CYP3A5—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00181	0.00302	CbGpPWpGaD
Fentanyl—CYP3A5—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.0018	0.003	CbGpPWpGaD
Fentanyl—CYP3A5—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00178	0.00298	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00176	0.00293	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00175	0.00293	CbGpPWpGaD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00173	0.00288	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00172	0.00288	CbGpPWpGaD
Fentanyl—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.0017	0.00285	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.0017	0.00285	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.0017	0.00284	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00169	0.00281	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00168	0.00281	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00165	0.00276	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00161	0.00269	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00159	0.00265	CbGpPWpGaD
Fentanyl—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00157	0.00263	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00156	0.00261	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00154	0.00258	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.0015	0.00251	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00149	0.00249	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00149	0.00248	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00148	0.00248	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00146	0.00244	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00138	0.00231	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00137	0.00229	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00135	0.00226	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00135	0.00225	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00134	0.00224	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00134	0.00224	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00132	0.0022	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00132	0.0022	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00132	0.0022	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.0013	0.00218	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.0013	0.00217	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00129	0.00216	CbGpPWpGaD
Fentanyl—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.00126	0.0021	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00126	0.0021	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00125	0.0021	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00122	0.00203	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00121	0.00202	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00121	0.00202	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.0012	0.00201	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00119	0.002	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00118	0.00198	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00118	0.00197	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00118	0.00197	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00117	0.00196	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00116	0.00194	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00115	0.00193	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00115	0.00193	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00114	0.00191	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00114	0.0019	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00113	0.00189	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00111	0.00186	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.0011	0.00184	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.0011	0.00184	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.0011	0.00184	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00107	0.00178	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00106	0.00177	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00105	0.00175	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00103	0.00173	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00102	0.00171	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00102	0.00171	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.001	0.00167	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000995	0.00166	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000992	0.00166	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000975	0.00163	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000975	0.00163	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000964	0.00161	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000963	0.00161	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000956	0.0016	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00093	0.00155	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000912	0.00152	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.0009	0.0015	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000897	0.0015	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000885	0.00148	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000874	0.00146	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000848	0.00142	CbGpPWpGaD
Fentanyl—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000841	0.00141	CbGpPWpGaD
Fentanyl—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000835	0.0014	CbGpPWpGaD
Fentanyl—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00083	0.00139	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000814	0.00136	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.0008	0.00134	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000797	0.00133	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00077	0.00129	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000743	0.00124	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000741	0.00124	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00074	0.00124	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000718	0.0012	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000707	0.00118	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000707	0.00118	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000706	0.00118	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000699	0.00117	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000697	0.00116	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000695	0.00116	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000676	0.00113	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000675	0.00113	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00065	0.00109	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000649	0.00108	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000646	0.00108	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000629	0.00105	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000628	0.00105	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000619	0.00103	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000611	0.00102	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000591	0.000987	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000586	0.00098	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00057	0.000953	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000569	0.000951	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000565	0.000944	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000558	0.000933	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000549	0.000917	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000539	0.0009	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000538	0.000898	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000532	0.000889	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000523	0.000873	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000516	0.000863	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000511	0.000853	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000511	0.000853	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000503	0.000839	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000481	0.000804	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000467	0.00078	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000455	0.000759	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—COMT—attention deficit hyperactivity disorder	0.000428	0.000715	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000425	0.00071	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000408	0.000682	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000399	0.000666	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000389	0.000649	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000385	0.000644	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000385	0.000644	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000379	0.000633	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000353	0.000589	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000344	0.000575	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000337	0.000563	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—COMT—attention deficit hyperactivity disorder	0.000309	0.000517	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000308	0.000515	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000307	0.000513	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000293	0.00049	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000241	0.000402	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000237	0.000397	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000237	0.000397	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000234	0.00039	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000234	0.00039	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000232	0.000387	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000217	0.000363	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000211	0.000353	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00019	0.000317	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—EP300—attention deficit hyperactivity disorder	0.000184	0.000307	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000181	0.000302	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000179	0.000298	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	0.000144	0.00024	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000143	0.000239	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—EP300—attention deficit hyperactivity disorder	0.000133	0.000222	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	0.0001	0.000167	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	6.17e-05	0.000103	CbGpPWpGaD
